Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: J Biol Rhythms. 2018 Jul 5;33(4):376–387. doi: 10.1177/0748730418782820

Figure 2.

Figure 2.

Effects of the NKCC1 inhibitor bumetanide injected into the SCN on the phase of the circadian locomotor rhythm in the early subjective night (CT 13.5). Top: Bumetanide did not produce phase shifts in the free-running locomotor rhythm at any concentration (p > 0.05). Middle and bottom: Representative wheel-running actograms for vehicle injection and 10 μM bumetanide injections, respectively. Gray boxes denote manipulation time point (i.e., drug treatment).